Anticoagulation therapy. ([2018])

• Record Type: Book
• Further Information: Note: Joe F. Lau, Geoffrey D. Barnes, Michael B. Streiff editors.
• Editors: Lau, Joe F; Barnes, Geoffrey D; Streiff, Michael B
• Contents: Intro; Preface; Acknowledgments; Abbreviations; Contents; 1: Introduction; Anticoagulation Therapy: A Historical Perspective; The Evolving Anticoagulant Armamentarium; Resources for Anticoagulation Management; Exploring the Future of Anticoagulation Care; References; Part I: Anticoagulants; 2: Warfarin; Introduction; Pharmacology; Mechanism of Action; Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; Pharmacodynamics; Clinical Utility; Practical Management; Patient Engagement and Education; Dosing: Initiation; Dosing: Maintenance; Administration; Monitoring. Transitioning Between Warfarin and Other AnticoagulantsManagement of Warfarin Around Elective Procedures; Adverse Effects; Skin Necrosis; Purple Toe Syndrome; Other Adverse Effects; Bleeding; Reversal; INR Derangements in Asymptomatic Patients; INR 9; Bleeding Events; Nonmajor Bleeding; Major Bleeding; Urgent or Emergent Procedures; Special Considerations; Pregnancy; Breastfeeding; Pediatric Patients; Conclusion; References; 3: Unfractionated Heparin and Low-ƯMolecular-ƯWeight Heparin; Introduction; Unfractionated Heparin; Pharmacokinetics and Pharmacodynamics. Clinical Indications and DosingMonitoring; Considerations in Special Populations; Obesity; Pregnancy; Strategies for Reversal of Unfractionated Heparin; Complications; Heparin Resistance; Osteopenia; Heparin-Induced Thrombocytopenia; Low-Molecular-Weight Heparin; Pharmacodynamics; Pharmacokinetics; Clinical Indications and Dosing; Considerations in Special Populations; Obesity; Renal Dysfunction and Elderly Patients; Pregnancy; Strategies for Reversal of Low-ƯMolecular-ƯWeight Heparins; Summary; References; 4: Parenteral Anticoagulants: Direct Thrombin Inhibitors and Pentasaccharides. Parenteral Direct Thrombin Inhibitors (Argatroban and Bivalirudin)Pharmacology; Mechanism of Action; Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; Pharmacodynamics; Clinical Utility; Heparin-Induced Thrombocytopenia (HIT); Argatroban; Bivalirudin; Coronary Reperfusion; Percutaneous Coronary Intervention (PCI) in Patients without HIT; Argatroban; Bivalirudin; Percutaneous Coronary Intervention (PCI) in Patients with HIT; Argatroban; Bivalirudin; Acute Myocardial Infarction (NSTEMI or STEMI) in Patients Who Cannot Undergo PCI; CABG with or Without HIT. Practical ManagementDosing; Administration; Monitoring and Titration; HIT; Coronary Reperfusion; Argatroban; Bivalirudin; Transitioning to Oral Anticoagulation; HIT; Argatroban; Bivalirudin; Coronary Reperfusion; Other Clinical Uses; Continuous Renal Replacement Therapy; ECMO; Adverse Effects; Reversal; Special Considerations; Pregnancy; Breastfeeding; Pediatric; Fondaparinux; Pharmacology; Mechanism of Action; Pharmacokinetics; Absorption; Distribution; Metabolism; Elimination; Renal Function; Age; Low Body Weight; Pharmacodynamics; Clinical Utility; Prevention of VTE; Orthopedic Surgery.
• Publisher Details: Cham, Switzerland : Springer
• Publication Date: 2018
• Copyright Date: 2018
• Extent: 1 online resource
• Subjects: 615.718; Anticoagulants (Medicine); Anticoagulants (Medicine) -- Therapeutic use; MEDICAL -- Pharmacology; Anticoagulants (Medicine); Anticoagulants (Medicine) -- Therapeutic use; Medicine & Public Health; Cardiology; Hematology; Angiology; Anticoagulants -- therapeutic use; Electronic books
• Languages: English
• ISBNs: 9783319737096; 3319737090
• Related ISBNs: 9783319737089; 3319737082
• Notes: Note: Includes bibliographical references and index.; Note: Vendor-supplied metadata.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.